On March 1, the FDA introduced that it’s increasing an import alert issued final July for all enoki mushrooms imported from the Republic of Korea to now additionally embody enoki mushrooms from China for detention and not using a bodily examination at U.S. borders (DWPE) to additional shield public well being.
Beforehand, this import alert solely included enoki mushrooms from the Republic of Korea. From Oct. 2020 via Feb. 2023, state public well being authorities performed a sampling of enoki mushrooms from retail areas. A number of state samples detected L. monocytogenes, which led to 18 remembers of enoki mushrooms within the U.S. since 2021. Eight of the remembers had been linked to enoki mushrooms grown within the Republic of Korea, and 10 from China, had been confirmed through labeling, traceback, or complete genome sequencing (WGS).
Throughout this time, FDA sampled and analyzed 127 shipments of enoki mushrooms imported from China and located 18 to be violative, representing a violation fee of greater than 14 p.c. This effort recognized 15 corporations with violative merchandise out of at the very least 37 declared corporations that had exported enoki mushrooms from China to the U.S.
Moreover, a latest FDA multi-state outbreak investigation linked three instances of listeriosis to enoki mushrooms labeled as a product of China.
Given the newest knowledge and knowledge, the FDA is increasing the country-wide import alert to topic enoki mushrooms from China to DWPE to assist forestall the importation of enoki mushrooms that seem to include human pathogens which may be injurious to public well being.
(To enroll in a free subscription to Meals Security Information, click on right here)